These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Insights and views about cardiovascular safety of COX2 inhibitors]. Wallentin L Lakartidningen; 2005 Feb 28-Mar 6; 102(9):666, 668, 671. PubMed ID: 15804041 [No Abstract] [Full Text] [Related]
15. Does celecoxib use increase the risk of cardiovascular events? Oviedo JA; Schroy PC Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088 [No Abstract] [Full Text] [Related]
16. [Cardiovascular complications with cyclooxygenase inhibitors : Myths and facts]. Brune K Z Rheumatol; 2010 Oct; 69(8):712, 714-8. PubMed ID: 20862483 [TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibitors--first, do no harm. Weatherall M; Aldington S; Shirtcliffe P; Caldwell B; Beasley R N Z Med J; 2005 Mar; 118(1211):U1359. PubMed ID: 15778758 [No Abstract] [Full Text] [Related]
18. Increased risk of cardiovascular events with coxibs and NSAIDs. Scott DG; Watts RA Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299 [No Abstract] [Full Text] [Related]
19. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity]. Ruilope LM; Coca A Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545 [No Abstract] [Full Text] [Related]